Haemonetics (HAE) Short Interest Ratio & Short Volume → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free HAE Stock Alerts $89.01 +0.67 (+0.76%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Haemonetics Short Interest DataCurrent Short Interest2,500,000 sharesPrevious Short Interest2,620,000 sharesChange Vs. Previous Month-4.58%Dollar Volume Sold Short$241.15 millionShort Interest Ratio4.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares50,840,000 sharesFloat Size50,320,000 sharesShort Percent of Float4.97%Today's Trading Volume799,032 sharesAverage Trading Volume620,214 sharesToday's Volume Vs. Average129% Short Selling Haemonetics ? Sign up to receive the latest short interest report for Haemonetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHAE Short Interest Over TimeHAE Days to Cover Over TimeHAE Percentage of Float Shorted Over Time Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here Haemonetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20242,500,000 shares $241.15 million -4.6%5.0%4.9 $96.46 4/30/20242,620,000 shares $241.17 million +17.0%5.2%5.3 $92.05 4/15/20242,240,000 shares $190.20 million +9.8%4.5%4.7 $84.91 3/31/20242,040,000 shares $174.11 million -6.4%4.1%4.5 $85.35 3/15/20242,180,000 shares $163.02 million +11.2%4.3%4.9 $74.78 2/29/20241,960,000 shares $143.02 million +6.5%3.9%4.7 $72.97 Get the Latest News and Ratings for HAE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Haemonetics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,840,000 shares $132.26 million +10.2%3.7%4.8 $71.88 1/31/20241,670,000 shares $127.65 million -1.8%3.3%5 $76.44 1/15/20241,700,000 shares $141.10 million -6.6%3.4%5.7 $83.00 12/31/20231,820,000 shares $155.63 million +9.0%3.6%6.3 $85.51 12/15/20231,670,000 shares $149.21 million -1.2%3.3%5.8 $89.35 11/30/20231,690,000 shares $136.69 million -6.1%3.4%6.1 $80.88 11/15/20231,800,000 shares $160.63 million +7.1%3.6%6.5 $89.24 10/31/20231,680,000 shares $143.19 million +18.3%3.4%5.9 $85.23 10/15/20231,420,000 shares $126.89 million -17.0%2.8%5 $89.36 9/30/20231,710,000 shares $153.18 million +6.9%3.4%5.9 $89.58 9/15/20231,600,000 shares $144.16 million +1.3%3.2%5.6 $90.10 8/31/20231,580,000 shares $141.77 million +21.5%3.2%5.4 $89.73 8/15/20231,300,000 shares $120.68 million -6.5%2.6%4.4 $92.83 7/31/20231,390,000 shares $128.07 million +6.9%2.8%4.6 $92.14 7/15/20231,300,000 shares $109.20 million -8.5%2.6%4.4 $84.00 6/30/20231,420,000 shares $120.90 million -2.7%2.8%5.1 $85.14 6/15/20231,460,000 shares $121.82 million +9.8%2.9%4.9 $83.44 5/31/20231,330,000 shares $112.62 million +23.2%2.7%4.5 $84.68 5/15/20231,080,000 shares $96.29 million +3.9%2.2%3.5 $89.16 4/30/20231,040,000 shares $87.06 million -21.2%2.1%3.2 $83.71 4/15/20231,320,000 shares $111.91 million +24.5%2.6%3.6 $84.78 3/31/20231,060,000 shares $87.72 million -13.1%2.1%2.6 $82.75 3/15/20231,220,000 shares $93.50 million -3.2%2.4%3 $76.64 2/28/20231,260,000 shares $97.99 million +2.4%2.5%3 $77.77 2/15/20231,230,000 shares $102.61 million -3.9%2.5%3 $83.42 1/31/20231,280,000 shares $108.29 million +2.4%2.6%2.8 $84.60 1/15/20231,250,000 shares $107.14 million +7.8%2.5%2.9 $85.71 12/30/20221,160,000 shares $91.23 million +4.5%2.3%2.8 $78.65 12/15/20221,110,000 shares $85.80 million -2.6%2.2%2.6 $77.30 11/30/20221,140,000 shares $97.25 million -7.3%2.3%2.8 $85.31 11/15/20221,230,000 shares $95.99 million -26.4%2.5%2.9 $78.04 10/31/20221,670,000 shares $141.87 million +1.8%3.3%3.9 $84.95 10/15/20221,640,000 shares $125.53 million +10.8%3.2%4 $76.54 9/30/20221,480,000 shares $109.56 million -14.0%2.9%3.8 $74.03Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now 9/15/20221,720,000 shares $133.54 million -7.5%3.4%4 $77.64 8/31/20221,860,000 shares $139.56 million +6.3%3.7%4.4 $75.03 8/15/20221,750,000 shares $132.79 million -3.9%3.5%4.2 $75.88 7/31/20221,820,000 shares $126.47 million -2.7%3.6%4 $69.49 7/15/20221,870,000 shares $119.85 million -2.1%3.7%4.1 $64.09 6/30/20221,910,000 shares $124.49 million +5.0%3.8%3.9 $65.18 6/15/20221,820,000 shares $112.46 million +7.1%3.6%3.8 $61.79 5/31/20221,700,000 shares $107.54 million -7.6%3.4%3.5 $63.26 5/15/20221,840,000 shares $103.48 million +8.2%3.6%3.6 $56.24 4/30/20221,700,000 shares $86.14 million +3.0%3.4%3.1 $50.67 4/15/20221,650,000 shares $93.75 million +0.6%3.3%2.9 $56.82 3/31/20221,640,000 shares $103.68 million -16.3%3.2%2.8 $63.22 3/15/20221,960,000 shares $105.60 million +8.9%3.9%3.3 $53.88 2/28/20221,800,000 shares $103.88 million +18.4%3.6%3 $57.71 2/15/20221,520,000 shares $88.75 million +23.6%3.0%2.6 $58.39 1/31/20221,230,000 shares $59.47 million +2.5%2.4%2.1 $48.35 1/15/20221,200,000 shares $63.23 million -1.6%2.4%2.4 $52.69 12/31/20211,220,000 shares $64.71 million -6.2%2.4%2.5 $53.04 12/15/20211,300,000 shares $65.82 million -3.0%2.6%2.8 $50.63 11/30/20211,340,000 shares $68.68 million -3.6%2.7%2.9 $51.25 11/15/20211,390,000 shares $80.48 million -15.8%2.8%3 $57.90 10/29/20211,650,000 shares $113.37 million -14.1%3.3%3.4 $68.71 10/15/20211,920,000 shares $134.23 million -4.5%3.8%4 $69.91 9/30/20212,010,000 shares $141.89 million -3.4%4.0%4 $70.59 9/15/20212,080,000 shares $140.48 million +3.0%4.1%3.3 $67.54 8/31/20212,020,000 shares $126.76 million -10.2%4.0%3 $62.75 8/13/20212,250,000 shares $137.57 million +23.0%4.5%3.1 $61.14 7/30/20211,830,000 shares $111.25 million -21.5%3.7%2.1 $60.79 7/15/20212,330,000 shares $140.36 million -26.5%4.6%2.4 $60.24 6/30/20213,170,000 shares $211.25 million +25.8%6.3%2.7 $66.64 6/15/20212,520,000 shares $149.46 million +5.9%5.0%2.4 $59.31 5/28/20212,380,000 shares $134.37 million +28.0%4.7%2.4 $56.46 5/14/20211,860,000 shares $96.37 million +25.7%3.7%2 $51.81 4/30/20211,480,000 shares $99.23 million -24.1%2.9%2 $67.05 4/15/20211,950,000 shares $227.97 million +23.4%3.9%3 $116.91 3/31/20211,580,000 shares $177.54 million -4.8%3.1%3.9 $112.37 3/15/20211,660,000 shares $195.00 million +59.6%3.3%4.4 $117.47 2/26/20211,040,000 shares $134.26 million +2.0%2.1%2.9 $129.10 2/12/20211,020,000 shares $138.53 million +45.4%2.0%3 $135.81 1/29/2021701,400 shares $80.46 million -35.1%1.4%1.9 $114.71 1/15/20211,080,000 shares $139.35 million -4.4%2.1%3 $129.03 12/31/20201,130,000 shares $134.38 million -3.4%2.2%3.2 $118.92 12/15/20201,170,000 shares $137.11 million -12.0%2.3%3.1 $117.19 11/30/20201,330,000 shares $151.26 million +31.7%2.7%3.3 $113.73 11/15/20201,010,000 shares $108.56 million -9.8%2.0%2.4 $107.49 10/30/20201,120,000 shares $116.76 million +15.6%2.2%2.4 $104.25 10/15/2020968,900 shares $90.70 million -1.3%1.9%1.8 $93.61 9/30/2020981,800 shares $85.66 million -16.1%2.0%0 $87.25 9/15/20201,170,000 shares $100.92 million -21.0%2.3%1.8 $86.26 8/31/20201,480,000 shares $132.70 million +17.5%3.0%2.1 $89.66This TSLA short trade is on a nine win hot streak (Ad)Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. 8/14/20201,260,000 shares $106.38 million +31.3%2.5%1.7 $84.43 7/31/2020959,500 shares $84.11 million +21.1%1.9%1.3 $87.66 7/15/2020792,100 shares $69.66 million -18.9%1.6%1.2 $87.94 6/30/2020976,500 shares $85.92 million -30.7%2.0%1.5 $87.99 6/15/20201,410,000 shares $125.63 million -0.7%2.8%2.4 $89.10 5/29/20201,420,000 shares $157.02 million +12.7%2.9%2.4 $110.58 5/15/20201,260,000 shares $126.55 million -6.7%2.5%2.3 $100.44 4/30/20201,350,000 shares $153.60 million -24.2%2.7%2.4 $113.78 4/15/20201,780,000 shares $183.55 million -12.8%3.6%3 $103.12 3/31/20202,040,000 shares $238.13 million +15.9%4.1%3.5 $116.73 3/13/20201,760,900 shares $176.90 million +96.7%3.5%3.7 $100.46 2/28/2020895,400 shares $77.45 million -7.3%1.8%1.9 $86.50 2/14/2020965,900 shares $100.41 million -38.5%1.9%2.3 $103.96 1/31/20201,570,000 shares $170.45 million +23.6%3.2%4 $108.57 1/15/20201,270,000 shares $150.15 million +25.7%2.5%3.7 $118.23 12/31/20191,010,000 shares $108.52 million -1.9%2.0%3.2 $107.45 8/15/2019798,900 shares $106.51 million -29.8%1.6%1.7 $133.32 HAE Short Interest - Frequently Asked Questions What is Haemonetics' current short interest? Short interest is the volume of Haemonetics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 2,500,000 shares of HAE short. 4.97% of Haemonetics' shares are currently sold short. Learn More on Haemonetics' current short interest. What is a good short interest ratio for Haemonetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HAE shares currently have a short interest ratio of 5.0. Learn More on Haemonetics's short interest ratio. What is a good short interest percentage for Haemonetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.97% of Haemonetics' floating shares are currently sold short. Is Haemonetics' short interest increasing or decreasing? Haemonetics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,500,000 shares, a decrease of 4.6% from the previous total of 2,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Haemonetics' float size? Haemonetics currently has issued a total of 50,840,000 shares. Some of Haemonetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Haemonetics currently has a public float of 50,320,000 shares. How does Haemonetics' short interest compare to its competitors? 4.97% of Haemonetics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Haemonetics: Merit Medical Systems, Inc. (4.01%), ICU Medical, Inc. (5.42%), Inspire Medical Systems, Inc. (6.23%), Glaukos Co. (6.45%), PROCEPT BioRobotics Co. (9.79%), Axonics, Inc. (7.04%), Tandem Diabetes Care, Inc. (14.01%), iRhythm Technologies, Inc. (9.84%), Inari Medical, Inc. (9.79%), NovoCure Limited (5.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Haemonetics stock? Short selling HAE is an investing strategy that aims to generate trading profit from Haemonetics as its price is falling. HAE shares are trading up $0.67 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Haemonetics? A short squeeze for Haemonetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HAE, which in turn drives the price of the stock up even further. How often is Haemonetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HAE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Merit Medical Systems Short Interest ICU Medical Short Interest Inspire Medical Systems Short Interest Glaukos Short Interest PROCEPT BioRobotics Short Interest Axonics Short Interest Tandem Diabetes Care Short Interest iRhythm Technologies Short Interest Inari Medical Short Interest NovoCure Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HAE) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.